AzTrials
AzTrials

Frail ElderlyNCT06701045

Prevalence of Malnutrition and Frailty Among the Urban Community Elderly in Bandung

An observational study of Frail Elderly, run by Universitas Padjadjaran at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this observational study is to learn prevalence of malnutrition and frailty in elderly in Community in Bandung. The main question it aims to answer: what is the prevalence of malnutrition and frailty in elderly in Bandung community? Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Frail Elderly
How many people
71 participants
Where
1 siteIndonesia
Study dates
1 Oct 2022to 31 Mar 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The subject were taken form in each district there were a community health center that has an program integrated program specialized for elderly in each subdistrict. We took the subject samples from elderly that regularly visit this subdistrict program.

Who may be able to join

  • age above 60 years old
  • domicile in Bandung City
  • able to mobilize without assistive devices
  • able to see and read
  • willing to participate in the study

Who cannot join

  • history of hospitalization within the previous month
  • Mini Mental Status Examination ( MMSE ) score < 24

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • Community Health Center

    Bandung, West Java, 40261

Other trials in Indonesia

About this study

The goal of this observational study is to learn prevalence of malnutrition and frailty in elderly in Community in Bandung. The main question it aims to answer:

what is the prevalence of malnutrition and frailty in elderly in Bandung community?

Read the detailed description

The increase in the number and proportion of the elderly population poses various challenges, especially in the health sector. The elderly tend to be more vulnerable to health problems, such as malnutrition and frailty. Data on the prevalence of malnutrition and frailty in the elderly can be used as a basis for taking preventive and treatment measures for both conditions. This study aims to determine the prevalence of malnutrition and frailty in the elderly in the Bandung City community.

Descriptive research with a cross-sectional approach was conducted on 71 elderly participants in the Bandung City community. The sampling method used was consecutive sampling. The study used the Mini Nutritional Assessment-Short Form (MNA-SF) questionnaire to assess malnutrition and the Kihon Checklist (KCL) to assess frailty.

Conditions
Frail Elderly
Keywords
frail, elderly, malnutrition, community
Medical subject headings
Malnutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06701045
Study groupRoleWhat they receive
Elderly living in communityThe inclusion criteria were domicile in Bandung City, able to mobilize without assistive devices, able to see and read and willing to participate in the study after informed consent.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Frailty

    Frailty is a condition of reduced ability to cope with stressors due to increased vulnerability caused by age-related physiological decline. Frailty score in this study will be measured using Kihon Checklist (KCL) questionnaire that has 24 questions divided into seven categories that are physical strength, nutrition, eating problems, socialization, memory, mood, and lifestyle. The result will bed categorized into not frail (0-3 points), pre-frailty (4-7 points) and frailty (> 8 points).

    Measured: On enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Nov 2024
  2. Study start1 Oct 2022
  3. Primary completion30 Nov 2022
  4. Study completion31 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
71 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06701045
Sponsor's protocol ID
IKFR-202411.01
Status last verified
Nov 2024
First submitted
13 Nov 2024
Last updated
22 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Small sample size

Questions about this trial

What is this clinical trial studying?

An observational study of Frail Elderly, run by Universitas Padjadjaran at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Frailty (time frame: On enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in